Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 144-153

  Yu, Lu ^a   Zhang, Wenliang ^a,c   Wang, Lingling ^a   Yang, Jian ^a   Liu, Tao ^a   Peng, Junping ^a   Leng, Wenchuan ^a   Chen, Lihong ^a   Li, Ruoyu ^d   Jin, Qi ^a,b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

^d Research Centre for Medical Mycology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; KETOCONAZOLE; RIBOSOME PROTEIN;

ANIMAL CELL; ARTICLE; DERMATOPHYTE; DNA LIBRARY; DNA MICROARRAY; DRUG MECHANISM; FATTY ACID METABOLISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIPID METABOLISM; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEROL METABOLISM; TRICHOPHYTON RUBRUM; UNINDEXED SEQUENCE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; KETOCONAZOLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRICHOPHYTON;

EID: 33845993642     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00755-06     Document Type: Article

References (40)

1. Agarwal, A. K., P. D. Rogers, S. R. Baerson, M. R. Jacob, K. S. Barker, J. D. Cleary, L. A. Walker, D. G. Nagle, and A. M. Clark. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278: 34998-35015.
2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Bammert, G. F., and J. M. Fostel. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob. Agents Chemother. 44:1255-1265.
4. Cervelatti, E. P., M. S. Ferreira-Nozawa, R. Aquino-Ferreira, A. L. Fachin, and N. M. Martinez-Rossi. 2004. Electrophoretic molecular karyotype of the dermatophyte Trichophyton rubrum. Genet. Mol. Biol. 27:99-102.
5. Cleveland, W. S. 1979. Robust locally weighted regression and smoothing scatterplots. J. Am. Stat. Assoc. 74:829-836.
6. De Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands, and University Rovirai Virgili, Reus, Spain.
7. Fernández-Torres, B., A. J. Carrillo, E. Martín, A. Del Palacio, M. K. Moore, A. Valverde, M. Serrano, and J. Guarro. 2001. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob. Agents Chemother. 45:2524-2528.
8. Fernández-Torres, B., F. J. Cabañes, A. J. Carrillo-Muñoz, A. Esteban, I. Inza, L. Abarca, and J. Guarro. 2002. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J. Clin. Microbiol. 40:3999-4003.
9. Fernández-Torres, B., I. Inza, and J. Guarro. 2003. In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes. J. Clin. Microbiol. 41:5209-5211.
10. Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
11. Ghannoum, M. A., and L. B. Rice. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:501-517.
12. Hartsel, S., and J. Bolard. 1996. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17:445-449.
13. Jackson, C. J., R. C. Barton, and E. G. V. Evans. 1999. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J. Clin. Microbiol. 37:931-936.
14. Jensen-Pergakes, K. L., M. A. Kennedy, N. D. Lees, R. Barbuch, C. Koegel, and M. Bard. 1998. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in ergo mutants. Antimicrob. Agents Chemother. 42:1160-1167.
15. Kemna, M. E., and B. E. Elewski. 1996. A U. S. epidemiologic survey of superficial fungal diseases. J. Am. Acad. Dermatol. 35:539-542.
16. Larone, D. H. 2002. Medically important fungi: a guide to identification, 4th ed. American Society for Microbiology, Washington, DC.
17. Liu, T. T., R. E. B. Lee, K. S. Barker, R. E. Lee, L. Wei, R. Homayouni, and P. D. Rogers. 2005. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49:2226-2236.
18. Mazur, P., N. Morin, W. Baginsky, M. El-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Poor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15: 5671-5681.
19. Melin, P., J. Schnurer, and E. G. Wagner. 2003. Characterization of phiA, a gene essential for phialide development in Aspergillus nidulans. Fungal Genet. Biol. 40:234-241.
20. Mukherjee, P. K., S. D. Leidich, N. Isham, I. Leitner, N. S. Ryder, and M. A. Ghannoum. 2003. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob. Agents Chemother. 47:82-86.
21. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
22. Niewerth, M., and H. C. Korting. 2000. The use of systemic antimycotics in dermatotherapy. Eur. J. Dermatol. 10:155-160.
23. Popolo, L., and M. Vai. 1999. The Gas1 glycoprotein, a putative wall polymer cross-linker. Biochim. Biophys. Acta 1426:385-400.
24. Ram, A. F. J., S. S. C. Brekelmans, L. J. W. M. Oehlen, and F. M. Klis. 1995. Identification of two cell cycle regulated genes affecting the β-1,3-glucan content of cell wall in Saccharomyces cerevisiae. FEBS Lett. 358:165-170.
25. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, A. Sturn, M. Snuffin, A. Rezantsev, D. Popov, A. Ryltsov, E. Kostukovich, I. Borisovsky, Z. Liu, A. Vinsavich, V. Trush, and J. Quackenbush. 2003. TM4: a free, open-source system for microarray data management and analysis. BioTechniques 34:374-378.
26. Sanglard, D. 2002. Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol. 5:379-385.
27. Smith, K. J., M. Welsh, and H. Skelton. 2001. Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients. Br. J. Dermatol. 145:344-348.
28. Spreghini, E., D. A. Davis, R. Subaran, M. Kim, and A. P. Mitchell. 2003. Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation. Eukaryot. Cell 2:746-755.
29. Squeo, R. F., R. Beer, D. Silvers, I. Weitzman, and M. Grossman. 1998. Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host. J. Am. Acad. Dermatol. 39:379-380.
30. Suschka, S., B. Fladung, and H. F. Merk. 2002. Clinical comparison of the efficacy and tolerability of once daily canesten with twice daily nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. Mycoses 45:91-96.
31. Szekely, A., E. M. Johnson, and D. W. Warnock. 1999. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J. Clin. Microbiol. 37:1480-1483.
32. Urban, M., T. Bhargava, and J. E. Hamer. 1999. An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease. EMBO J. 18:512-521.
33. Vanden Bossche, H., D. W. Warnock, B. Dupont, D. Kerridge, S. Sen Gupta, L. Improvisi, P. Marichal, F. C. Odds, F. Provost, and O. Ronin. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32(Suppl. 1):189-202.
34. Vanden Bossche, H., G. Willemsens, and P. Marichal. 1987. Anti-Candida drugs-the biochemical basis for their activity. Crit. Microbiol. Rev. 15:57-72.
35. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
36. Vander Straten, M. R., M. A. Hossain, and M. A. Ghannoum. 2003. Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor. Infect. Dis. Clin. N. Am. 17:87-112.
37. Venkateswarlu, K., D. E. Kelly, N. J. Manning, and S. L. Kelly. 1998. NADPH cytochrome P-450 oxidoreductase and susceptibility to KTZ. Antimicrob. Agents Chemother. 42:1756-1761.
38. Vermilion, J. L., D. P. Ballou, V. Massey, and M. J. Coon. 1981. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase. J. Biol. Chem. 256:266-277.
39. Weitzman, I., and R. C. Summerbell. 1995. The dermatophytes. Clin. Microbiol. Rev. 8:240-259.
40. Zhang, L., Y. Zhang, Y. Zhou, S. An, Y. Zhou, and J. Cheng. 2002. Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J. Antimicrob. Chemother. 49:905-915.